LEVETIRACETAM ORAL SOLUTION USP

LEVETIRACETAM ORAL SOLUTION USP

  • Unit Dose
  • Bottle

Overview

NDC #
Strength
Product/Case Size
NDC #
00121-4799-40
Strength
500 mg
Product/Case Size
5 mL/40 cs
NDC #
00121-4799-50
Strength
500 mg
Product/Case Size
5 mL/50 cs
NDC #
00121-1598-20
Strength
1,000 mg
Product/Case Size
10 mL/20 cs
NDC #
00121-0799-16
Strength
500 mg/5 mL
Product/Case Size
16 oz/12 cs
00121-4799-40
500 mg
5 mL/40 cs
00121-4799-50
500 mg
5 mL/50 cs
00121-1598-20
1,000 mg
10 mL/20 cs
00121-0799-16
500 mg/5 mL
16 oz/12 cs

Wholesale Ordering

NDC #
Cardinal
Cencora
McKesson
Morris Dickson
NDC #
00121-4799-40
Cardinal
5402631
Cencora
10183527
McKesson
3733904
Morris Dickson
189787
NDC #
00121-4799-50
Cardinal
5668116
Cencora
10260104
McKesson
1559707
Morris Dickson
221135
NDC #
00121-1598-20
Cardinal
5822176
Cencora
10276444
McKesson
2669976
Morris Dickson
241570
NDC #
00121-0799-16
Cardinal
5223060
Cencora
10160686
McKesson
3499092
Morris Dickson
571158
00121-4799-40
5402631
10183527
3733904
189787
00121-4799-50
5668116
10260104
1559707
221135
00121-1598-20
5822176
10276444
2669976
241570
00121-0799-16
5223060
10160686
3499092
571158

Barcodes

NDC #
GTIN Product Barcode
GTIN Case Barcode
NDC #
00121-4799-40
GTIN Product Barcode
GTIN Case Barcode
NDC #
00121-4799-50
GTIN Product Barcode
GTIN Case Barcode
NDC #
00121-1598-20
GTIN Product Barcode
GTIN Case Barcode
NDC #
00121-0799-16
GTIN Product Barcode
GTIN Case Barcode
00121-4799-40
00121-4799-50
00121-1598-20
00121-0799-16
Download Barcode Brochure

Key Info

Compared to: KEPPRA®

Free From:

Alcohol, dye, lactose, sugar

Rx or OTC:

Rx

Flavor:

Grape

Storage & Handling:

Store at 20° to 25°C (68° to 77°F). Dispense in a tight, light-resistant container with a child-resistant closure.

Indications:

  • Treatment of partial-onset seizures in patients 1 month of age or older
  • Treatment of myoclonic seizures in patients with juvenile myoclonic epilepsy in patients 12 years or older with juvenile myoclonic epilepsy
  • Adjunctive therapy for the treatment of primary generalized tonic-clonic seizures in patients 6 years of age or older with idiopathic generalized epilepsy
Please see full Prescribing Information for more information.